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Ozone is an intrinsically toxic gas and its hazardous
employment has led to a poor consideration of ozone
therapy. The aim of this review is to indicate that a
wrong dogma and several misconceptions thwart
progress: in reality, properly performed ozone
therapy, carried out by expert physicians, can be
very useful when orthodox medicine appears inade-
quate. The unbelievable versatility of ozone therapy
is due to the cascade of ozone-derived compounds
able to act on several targets leading to a multi-
factorial correction of a pathological state. During the
past decade, contrary to all expectations, it has been
demonstrated that the judicious application of ozone
in chronic infectious diseases, vasculopathies, ortho-
pedics and even dentistry has yielded such striking
results that it is deplorable that the medical establish-
ment continues to ignore ozone therapy.
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Introduction
I beg the readers’ pardon if this review has been
written in a personal way but it was meant to express
the reflections of an old ozone therapist, even though
the actual title was finally selected to emphasize the
controversial actions of ozone.
In 1988, I was still interested in evaluating inter-
feron (IFN) inducers and, by mere coincidence, I
wondered whether ozone, like galactose oxidase and
periodate, could induce the production of IFN-g on
human blood mononuclear cells. Under very precise
experimental conditions and using low doses of
ozone, it could, but was a weak inducer compared
with classical mitogens. Nonetheless I became fasci-
nated by this natural gas that appeared to have
controversial effects on earth and was hardly ac-
cepted in medicine. When Schoenbein discovered
ozone in 1834, he considered it not only an oxidant,
but also a disinfectant that unfortunately did not help
him when, in 1868, he got a deadly anthrax infection.
During the First World War it was used as a heroic
therapy of gangrene and today it is widely employed
for the sterilization of water. Wehrli and Steinbarth
1
were the first to expose human blood to oxygen plus
ultraviolet irradiation, but Wolff
2 invented the simpler
technique of exposing blood directly to a gas mixture
composed of oxygen/ozone. Thus, was born the
ozonated autohemotherapy (O3-AHT) procedure that
has been used millions of times. Since 1990, I realized
that a standard method did not exist and even today
some ozone therapists shamefully still use polyvinyl
chloride autotransfusion bags and some evaluate the
ozone effect by the change in color of blood (!) rather
than the actual ozone concentration. Is O3-AHT an
act of faith, then, a simple placebo treatment, or can it
be an effective therapeutic treatment?
The purpose of this review is to present evidence
that if we seriously tackle this problem, we can
propose it as an efficacious therapy but, for doing so,
we must know how ozone behaves within the
biological system and its inherent advantages and
disadvantages. It comes as no surprise that this
topic today is dominated by prejudices and most
ozone therapists believe that obstruction to this
therapy comes from pharmaceutical industries, while
in fact the main opponents are Health Authorities that
do not care to assess its merit. As skepticism is
antithetic to science, this paper aims to establish the
truth.
How can ozone act?
For several years my collaborators and I have made
an effort to establish the fate and effects of ozone
when blood ex vivo is exposed to it.
3 First, for in
vitro studies, we established a standard method
technically identical (except blood volume) to the
classical O3-AHT performed in patients. Five milli-
litres of human blood is precisely exposed to 5 ml of
either pure oxygen (control) or to a gas mixture
composed of both oxygen (95/99.9%) and ozone
(0.1/5%). A modern medical generator, equipped
with a photometer, can deliver precise ozone con-
centrations between 1 and 100 mg/ml where the
ozone, relative to the oxygen concentration, varies
between 0.1 and 5%. Thus, there is a sort of
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3stoichiometric relationship between ozone and blood
that unavoidably has an individual variability in terms
of hematocrit value, plasma antioxidant capacity and
cell composition. Immediately after the gas addition,
the blood, to avoid foaming, is gently mixed for 5 min
and during this period both gases dissolve into the
plasmatic water. While the pO2 values rise from about
40 mmHg up to a plateau of 500 mmHg within 5 min
and remains stable, the solubilized ozone reacts
instantaneously with the available antioxidant and
polyunsaturated fatty acids present in plasma. The
peroxidation reaction leads to the formation of
hydrogen peroxide (H2O2) and a mixture of lipoper-
oxides and then to end products, namely malonyl-
dialdehyde and 4-hydroxy-2,3-alkenals of variable
chain lengths, collectively known as lipid oxidation
products (LOPs).
4 Thus, within the most used range
of ozone concentrations (10/40 mg/ml of blood,
equal to 0.21/0.84 mM), we distinguish two classes
of compounds. The first is represented by the fast-
acting (half-lifeB/1 sec) reactive oxygen species
(ROS), among which H2O2 is the most important.
The second is due to LOPs, measured as thiobarbi-
turic acid-reactive substances (TBARS), that have a
relatively long half-life and will act mostly on
parenchymal cells, once the ozonated blood is
reinfused into the donor. While we readily measure
H2O2 after human plasma ozonation with a half-life
of about 2 min, its appearance in blood is so
transitory that it cannot be assessed. H2O2 diffuses
freely across plasma membranes and the enormous
number of erythrocytes mops it up in a matter of
seconds. Moreover blood cells, being particularly rich
in reduced glutathione (GSH), catalase and glu-
tathione peroxidase (GSH-Px), reduce H2O2 so
quickly that its intracellular concentration is merely
a 10% of the plasmatic one.
5,6 This finding is
important because intracellular concentrations above
1 mM can be damaging. The formation of this H2O2
gradient is crucial for understanding how ozone acts:
there is no doubt that blood must be exposed for
about 5 min to an ozone dose that, although largely
quenched by the plasmatic antioxidants, acting as
sacrificial reactants (ascorbic and uric acids, free
cysteine, GSH and /SH groups of albumin), elicits
the formation of both ROS and LOPs indispensable
for activating several biochemical, immunological
and pharmacological mechanisms responsible for
the biological and therapeutic effects. It must be
emphasized that the ozone dose must suffice in
inducing an acute, precise and transitory oxidative
stress, and obviously either a very low or a high dose
can be either ineffective (placebo) or toxic, respec-
tively.
Two important questions needed to be answered.
The first regarded the kinetics of total antioxidant
status (TAS) levels
7 after ozonation. Samples of
normal human blood and relative plasmas were
exposed to oxygen and two ozone concentrations:
40 mg/ml (0.84 mM) and 80 mg/ml (1.68 mM) (usual
1:1 v ratio). The TAS values of plasma was not
modified by O2, while ozonation caused a significant
decrease of 41% and 52%, respectively, 10 min after
the addition of ozone, when the decrease remained
static and the double concentration of ozone did
not further lower TAS levels. Then we tested the
blood samples and were so puzzled by the results
that we repeated the experiment twice to be really
sure. As expected, oxygen was ineffective while two
levels of ozonation (40 and 80 mg/ml) caused a
smaller decrease than in plasma (which was only 21%
and 33% respectively) after 1 min; then, surprisingly,
the TAS values began to rise progressively and
returned to the pre-ozonation level within 20 min.
A reasonable interpretation of these results is that
the presence of erythrocytes in the blood, in spite
of ozonation, is able to regenerate antioxidants
and quickly normalize TAS levels because erythro-
cytes can rapidly reconstitute the antioxidant reser-
voir. May et al.
8 and the data of Mendiratta et al.
9
support this interpretation very well. We asce-
rtained that in the same blood samples, ozonation
had taken place because while TBARS
10 increased
three and five times, Protein Thiol Group levels
11
decreased correspondingly but hemolysis remained
negligible (no more than 0.4%). Hemolysis increased
progressively from 0.5 to 7% only when ozone
concentrations rose from 100 up to 200 mg/ml per
ml of blood.
The second question was whether ozonation of
blood led to peroxidation of plasma membrane
phospholipids. This was and still is a vexed question,
because in the past several papers
1215 have reported
that erythrocytes isolated from plasma, after washing
and resuspension in a physiological medium, under-
went structural change and intense hemolysis when
exposed to ozone. It is unfortunate that these data
greatly contributed to the belief in ozone toxicity; in
fact, they are misleading because erythrocytes, de-
prived of plasma antioxidants and their natural
albumin shield, are obviously very sensitive to ozone.
The best proof of this erroneous belief is represented
by Shinriki et al.
16 and our data;
17,18 1 ml of citrated
human blood exposed to a concentrations as high as
100 mg/ml yielded only 0.2% and 0.5% hemolysis,
respectively. Moreover, Shinriki et al.
16 further de-
monstrated that TBARS are derived only from lipids
present in plasma and not from erythrocytic mem-
branes. In agreement with these results, they noted
only an ozone-dependent depletion (about 20%) of
alpha tocopherol in plasma. Indeed other studies
have clearly shown that when erythrocytes are
protected by plasmatic antioxidants, peroxidation of
membrane phospholipids is absent.
1923 In practical
terms, it appears that only one (probably an old cell)
out of 200/400 erythrocytes undergoes breakdown,
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These data establish that the ozone concentration
must be precise, as today we are using ozone as a
real drug. The sudden generation of H2O2 in the
plasma and the transitory and far lower concentration
of H2O2 in the cytoplasm mean that H2O2 is one of
the ozone messengers, and its level is critical because
it must be above a certain threshold to be effective
but not too high to overwhelm antioxidants and
become toxic. This state of the art has several
implications:
. The ozonation procedure on blood induces
only a calculated and very transitory oxidative
stress that is promptly normalized by the
powerful recycling of oxidized compounds
to antioxidants.
. There is a negligible hemolysis, from the basic
value of about 0.5% up to 1.2% if the antic-
oagulant is citrate and up to 1.8% if it is
heparin. Shinriki et al.
16 reported lower values
than ours: from 0 to 0.27%. However, as
expected, washed erythrocytes yield a 10%
value
13 and even higher values when blood is
ozonized with excessive ozone doses (up to
200 mg/ml). The enhanced hemolysis of
heparinized blood is probably favored by
a concomitant Ca
2 influx. These data
establish that the ozone concentration should
never exceed 80 mg/ml per ml of blood (1.68
mM).
. Osmotic fragility of Ca
2-chelated blood is
not evident even when an ozone concentra-
tion of 200 mg/ml is used and the hemolysis
curve is moderately displaced to the left even
in washed erythrocytes.
13
. Levels of methemoglobin remain practically
normal. Shinriki et al.
16 reported a variation
from 1.919 /0.11% to 2.219 /0.09% and we
have always measured lower levels (i.e. about
1% in comparison to hemoglobin).
. The hematocrit value does not change,
implying no modification of the erythrocytic
volume due to osmotic swelling or erythrocy-
tic lysis.
. At high levels of ozonation, there is a mini-
mal loss of K
, which rapidly returns to
normal.
16
. The blood antioxidant system adequately
protects erythrocytic enzymes such as Na/K-
ATPase, acetylcholinesterase in blood expo-
sed to ozone concentrations of 80 mg/ml,
16,24
as well as superoxide dismutase, GSH-Px,
GSH reductase and glucose 6-phosphate de-
hydrogenase (G6PDH).
25
A concise summary of biological effects
observed after ozone therapy
Erythrocytes
These cells respond with an activation of glycolysis
due to activation of the pentose phosphate pathway.
We found increased adenosine triphosphate levels
(from 13899 /260 to 19689 /232 mM) in patients with
age-related macular degeneration (ARMD) (atrophic
form) after a therapeutic cycle (14 sessions) of
O3-AHT.
26 Moreover, Viebahn
27 reported the same
effect in athletes and elderly patients after rectal
insufflation of O2/O3. Ozonation implies a small but
consistent oxidation of GSH to glutathione disulfide,
and GSH reductase utilizes the reduced form of the
coenzyme nicotinamide adenine dinucleotide phos-
phate supplied by G6PDH to reduce glutathione
disulfide to GSH, which indeed returns rapidly to
the original level.
28 The increase of 2,3-diphospho-
glycerate varies depending on the basic level in
ARMD patients and only those who had a low level
showed a marked increase with therapy. Viebahn,
27
after a longer cycle of therapy in elderly people,
observed a significant increase. An increase of 2,3-
diphosphoglycerate level in oxyhemoglobin shifts to
the right (p50 value increases); its dissociation curve
implies an increased delivery of O2 into the hypoxic
tissues. The life-span of ozonated
99Tc-labeled ery-
throcytes and their uptake by liver and spleen are
comparable with oxygenated erythrocytes.
3
A problem still under study regards the generation
of biochemically improved erythrocytes during pro-
longed ozone therapy. While ROS have an extremely
short life, LOPs, during the reinfusion of ozonated
blood, return into the donor’s circulation. While they
are fairly stable in vitro, they rapidly disappear from
blood in vivo owing to considerable dilution into
body fluids, degradation by aldehyde dehydro-
genases, excretion into bile and urine, and uptake
in various organs including bone marrow cells. This
process is crucial for explaining the mechanism of
ozone tolerance: during erythrogenesis, submicro-
molar LOP concentrations can upregulate the synth-
esis of antioxidant enzymes and indeed, after
appropriate density gradient separation, we have
found that young (lighter) erythrocytes contain
more G6PDH than older (heavier) cells generated
before the therapy.
25 This result suggests that ozone
therapy enhances the generation of erythrocytes with
improved metabolic characteristics, a sort of ‘super-
gifted erythrocytes’ able to correct hypoxia in vas-
cular diseases.
Leukocytes
These were the cells that we examined first as we
hypothesized that ozone could act as an IFN-g
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29 Since then we have shown
30,31 that ozone
behaves as a weak (compared with mitogens)
cytokine (such as tumor necrosis factor-a, interleu-
kin-2, interleukin-6, interleukin-8, transforming
growth factor-b [TGF-b]) inducer. Several studies
3235
have confirmed that ozone can stimulate bronch-
oalveolar cells to release proinflammatory cytokines
and eicosanoids. Thanks to parallel progress in
understanding the role of antioxidants and redox
regulation of gene transcription, it has been clarified
that, among several signals, H2O2 is one of the most
significant cytokine inducers.
36 As already men-
tioned, after ozonation H2O2 freely diffuses into the
leukocyte cytoplasm and activates specific protein
kinases that, by phosphorylating IkB bound to the
nuclear factor-kB allows the migration of the tran-
scription heterodimer p50/p65 into the nucleus
where it activates gene expression.
37 Obviously
H2O2 must reach a concentration able to activate
the kinase without being instantaneously reduced by
intracellular antioxidants.
38 Therefore the relevance
of the response depends on the levels of H2O2, which
can act as either ‘life or death’ signals. The fact that
ozone can either be a toxic or a useful signal depends
on the minimal antioxidant capacity of the respiratory
tract lining fluid, whereas blood has a very potent
capacity. Our data in fact indicate that too little ozone
(hence H2O2) is ineffective and too much (or too little
antioxidants) can be toxic. During recent years we
addressed the following questions: first, as ozone acts
as a mild cytokine inducer, does reinfusion of
ozonated blood modify the plasma cytokine level
in vivo? Second, does the induction of oxidative
stress proteins, particularly of heme-oxygenase I
(HO-I), and of adaptation to the therapeutic oxidative
stress have an immunomodulatory effect? And third,
can we devise an optimal schedule for improving the
immune reactivity in immunodepressed patients?
The classical O3-AHT, usually consisting of 225 ml
of blood (plus 25 ml of 3.8% sodium citrate solution)
treated with 225 ml of gas (O2/O3) with ozone
concentrations ranging from an initial 20 mg/ml
slowly scaled up to 40/50 mg/ml per ml of blood,
continued for several months, twice weekly, is ideal
for this purpose. A probable explanation is that, after
each blood reinfusion, a small percentage of immune
cells are activated and home in several organs: these
cells release into the microenvironment cytokines
that, in turn, prime or activate neighboring cells thus
slowly reinforcing immune responses. Modifications
of cytokine plasma levels are hardly detectable so
that side effects like the flu-like syndrome, typically
observed after administration of immunoadjuvants,
are absent
39 and actually most of patients report a
sense of well-being during the therapy. There is a
wealth of experimental data
4044 showing that both
animals and plants can develop ozone tolerance by
upregulating the expression of antioxidants, which
can correct a chronic imbalance between excessive
endogenous oxidation due to viral infections, cancer,
chronic inflammations and depressed antioxidants.
Both chronic hepatitis C virus and cancer patients
have shown a marked improvement of their clinical
conditions after several months of O3-AHT treat-
ments, suggesting that this ‘calculated and brief
oxidative stress’ truly merits the term ‘therapeutic
shock’.
Platelets
It is known that ROS can induce platelet activation
and it was obvious to assume that blood ozonation,
by generating H2O2, could cause it.
45,46 Moreover
H2O2 or other ROS can activate phospholipase C,
phospholipase A2, cyclo-oxygenases and lipo-oxyge-
nases and thromboxane synthetase, allowing a step
increase of intracellular Ca
2, release of prostaglan-
din E2, prostaglandin F2a and thromboxane A2 with
irreversible platelet aggregation. For these reasons
we studied the behavior of either human platelet
rich-plasma anticoagulated with heparin or citrate,
either untreated or simply oxygenated, or ozonated
at three concentrations (20, 40 and 80 mg/ml).
Because the plasmatic Ca
2 level potentiates the
ozone effect, we were not surprised to observe a
rapid platelet aggregation in heparinized plasma
particularly at the highest concentration.
47 Con-
sequently the release of several growth factors like
platelet-derived growth factor AB, TGF-b1, interleu-
kin-8 and thromboxane/2 were significantly higher
from heparinized platelets than Ca
2-free platelets.
48
These results taught us that it is better to chelate Ca
2
for performing a safe autohemotherapy. Nonetheless
the release of growth factors from Ca
2-free platelets
is still important because the reinfusion of ozonated
blood implies an elevation of plasma levels of TGF-b
that may explain why the healing of necrotic ulcers in
hind limb ischemia due to atherosclerosis and
diabetes markedly quickens during treatment with
both parenteral (O3-AHT) and topical treatments with
ozonated water and oil.
49,50
Endothelial cells and the vascular system
During the reinfusion of ozonated blood, the en-
dothelium comes in contact with traces of LOPs that
soon disappear in vivo.W e
51 then investigated the
effect of addition of ozonated (40 and 80 mg/ml)
human plasma to human endothelial cells in culture
and we measured a significant increase of the critical
relaxing factor NO+ that was ozone dose dependent.
The induction of nitric oxide synthase and the release
of NO+ was reinforced in the presence of 20 mmo f
arginine and was abolished by the addition of 20 mM
of L-N-omega-nitro-L-arginine methyl ester. In phy-
siological conditions the endothelium regulates the
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52 by producing some 1/10 mMo fN O +
and 1 nM of anion superoxide (one of the contracting
factors). The intravascular half-life of NO+ is about 2
msec with a strictly localized consumption so that the
likelihood of improving vasodilation in remote is-
chemic areas (the macula or the limbs) seems
negligible. However, NO+ readily reacts with GSH,
cysteine, albumin and hemoglobin (cysteine residue
b 93) and the formed S-nitrosothiols and S-nitroso-
hemoglobin have half-lives of 5/50 min, allowing a
pharmacological effect at distant sites.
53,54 It remains
to be ascertained whether ozonated blood enhances
the release of prostacyclin (PGI2) and angiopoietins,
both important factors for improving ischemic vascu-
lopathies.
Parenchymal cells in other organs
Upon reinfusion of ozonated blood, LOPs can reach
other organs such as the hypothalamus, endocrine
glands, liver, kidneys and bone marrow. The phe-
nomenon of adaptation to the repeated and acute
oxidative stress imposed by O3-AHT is most interest-
ing and able to elicit crucial therapeutic responses.
During prolonged treatment, cells throughout the
body receive small and gradual pulses of LOPs that
are responsible for: (1) neuro-endocrine responses
explaining the reported feeling of wellness,
55 (2) the
upregulation of antioxidant enzymes in several cell
types that is an excellent way to re-equilibrate the
oxidant/antioxidant unbalance, and (3) inducing a
number of stress or heat shock proteins (HSPs) such
as HSP27, HO-1 (HSP 32), HSP72 and HSP90.
5659 We
are particularly interested in HO-1 because this is a
protective enzyme allowing the formation of Fe
2,
bilirubin (an antioxidant) and carbon monoxide
(CO), a vasodilator that, like NO+, increases the level
of cyclic guanosine monophosphate, the reaction
catalyzed by guanylate cyclase.
Besides gases produced by the gut flora, it is truly
remarkable that cells can release other gaseous
molecules (NO+, CO and CO2), and it is even more
surprising that even ozone can be produced by
activated antibody-coated neutrophils.
60 These gases
can now be considered as molecules able to deliver
crucial physiological and pharmacological effects.
Excessive amounts of these molecules are toxic,
causing serious pathological events and possibly
death. Nature teaches us that these gases, depending
on their concentrations, can be either friends or foes
and, similarly, ozone therapy can be either useful or
toxic. If this reasoning is correct, ozone therapy,
when judiciously performed, is a simple, inexpensive
and atoxic approach with the advantage of activating
several biomechanisms in different cells unusually
leading to an integrated and often incredible re-
sponse.
The extreme versatility of ozone therapy
The sarcastic comment of the opponents is that
ozone therapy looks like a panacea for all diseases.
Indeed it seems so, but in reality this is due to the
multitude of compounds originated at first from the
reaction of ozone with body fluids, and eventually
able to display pleiotropic effects delivered by
different organs. For the sake of brevity I can only
summarize the therapeutic effects so far reported.
Acute and chronic bacterial, viral and fungine
infections
Intuitively, ozone therapy is very useful in both acute
and chronic bacterial, viral and fungine infections
because the generated ROS are the natural and most
effective agents to which even antibiotic resistant
pathogens do not resist.
3,61 Moreover, improvement
of metabolism and immunological functions contri-
bute to a favorable outcome. Abscesses, anal fissures,
fistulae, bed sores, furunculosis, inveterate osteomye-
litis, vulvovaginitis, necrotizing fasciitis and torpid
ulcers of various origin have been shown to improve
rapidly, particularly using the combination of
O3-AHT with topical treatment using either direct
O2/O3 exposure or the cleansing and stimulating
effect of ozonated water and oil. The activity of
ozonated solutions in eliminating the infectivity and
enhancing healing is almost unbelievable. However,
in Western countries accustomed to the use of
antibiotic creams (often with corticosteroids) there
is no mental attitude to profitably use the inexpensive
and most active ozonated oil.
62
Ischemic diseases
Chronic limb ischemia (atherosclerosis, diabetes,
Burger’s disease) is most effectively treated at
stage II-b with complete disappearance of pain and
claudication. Moreover, since 1981, Rokitansky
et al.
49 demonstrated that a cycle of O3-AHT (usually
14 treatments) led to a very good improvement in
70.6% and 53.8% of either stage III or stage IV
(Fontaine) patients, respectively. Amputation of toes
and limbs could be avoided in pre-terminal phases.
These results have been amply confirmed by Giunta
et al.,
63 Mattassi et al.
64 and Tylicki et al.
65 Pre-
terminal patients with chronic heart ischemia and no
further susceptibility to conventional treatments have
shown marked improvement after a cycle of 14
treatments of extracorporeal circulation of blood
against O2/O3.
66 A randomized controlled study is
in progress for establishing the validity of this more
invasive method than classical O3-AHT.
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A 6-year study in 90 patients with the ‘dry’ form of
ARMD has been carried out performing a cycle of
13/14 O3-AHT treatments. Mean distance best-cor-
rected visual acuity was significantly improved in the
treatment group of patients while in the control
group, first treated with oxygenated autohaemother-
apy, only a modest and not significant improvement
in mean distance visual acuity was observed. No
adverse effects have been noted and the patient’s
compliance has been excellent.
26 Owing to the
constant increase of ARMD patients and the lack of
an effective conventional treatment, this approach
appears mandatory.
Orthopedic diseases
Until recently it was unthinkable that a mixture of
O2/O3 could be useful in orthopedics. Indeed
lumbar disk herniation and osteoarthritis, although
having different etiologies, have a common inflam-
matory background expressed by a localized chronic
oxidative stress due to excessive production of ROS,
release of proinflammatory cytokines and activation
of cycloxygenases. Common sense would proscribe
the use of ozone, a master generator of free radicals
and, as it is well shown,
34,67 after pulmonary ex-
posure, a superb inflammatory agent. Contrary to all
expectations, it is now well demonstrated
68 that
combined intradiscal and periganglionic injection of
medical ozone allows an excellent outcome in 70.3%
of patients treated for disk herniation performed after
conservative management failed to respond. In the
same vein, it appears very surprising that the
application of medical ozone in acute and chronic
painful diseases of the joints allows rapid pain relief,
disappearance of inflammation and improvement of
mobility. Thousands of patients have been success-
fully treated and the lack of side effects is note-
worthy.
69
These positive empiric observations need to be
explained. Ozone is indeed a surprising gas that
paradoxically, after prolonged administration at low
concentrations, induces tolerance, a phenomenon
termed ‘hormesis’ by Goldman
70 to indicate ‘a
beneficial effect of a low level exposure to an agent
that is harmful at high levels’. Thus, at this stage, I use
the definition of ‘ozone paradox’ for explaining these
excellent therapeutic results. Immediately after
O2/O3 administration in the nucleus pulposus, or
into inflamed endoarticular cavities, a sort of oxida-
tive shock seems to subvert all the traditional
rules by inducing an antioxidative response due to
several factors, among which is the cholinergic anti-
inflammatory pathway.
71 A detailed discussion is
reported elsewhere.
3
Dentistry
This is another medical specialty where ozone has
been recently evaluated with exceedingly interesting
results.
72 Primary root carious lesions are being
treated with a novel ozone delivery system able to
avoid any toxic risk for the mouth cavity and
lungs. The tooth’s lesion is exposed for 10/20 sec
to a sort of ozone ‘hurricane’ based on a gas flow of
615 ml/min of O2/O3 at a low concentration
(4 mg/ml), perfectly enclosed in a tightly fitting
silicone cup enclosing the tooth. It is not surprising
that all bacteria, particularly lactobacilli, are de-
stroyed so that the ozone-sterilized dental surface
becomes quickly remineralized, becoming hard and
resistant to further bacterial attack. This new
approach is simple, inexpensive and well tolerated,
as opposed to the conventional and painful ‘drilling
and filling’ management of primary root carious
lesions.
Dermatological, pulmonary, renal,
hematological and neurodegenerative diseases
Owing to the ability of ozone to activate a number of
biological targets, ozone therapy could be profi-
ciently used in some dermatological, pulmonary,
renal, hematological and neurodegenerative diseases.
However these pathologies so far have not been
evaluated in a controlled fashion. Most of the patients
with metastatic cancer resistant to radiotherapy and
chemotherapy report a striking improvement of the
quality of life with prolonged (twice weekly for
months) O3-AHT treatments.
25,73 This is a constantly
observed result, most probably due to a multifactorial
neuroendocrine response.
Summary
Finally it must be emphasized that if ozone is
judiciously used according to precisely defined
guidelines, it causes neither acute, nor chronic side
effects. After two decades of practical applications
and the results observed in patients after conven-
tional remedies have proved unsatisfactory, one has
the feeling that, if ozone therapy could be accepted
and used in all hospitals, it would represent a small
but important medical revolution able to cure or
stabilize several diseases in many patients in both rich
and poor countries.
Discussion and conclusions
There is no doubt that ozone can be toxic, and even
today its hazardous employment by charlatans and
unprepared physicians has contributed to a poor
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why the use of ozone is prohibited in some states of
the USA and why this therapy is still regarded with
skepticism by orthodox medicine even in Germany,
where this approach was first conceived. Moreover,
the following data tend to generalize that ozone is
always toxic and should not be used in medicine:
1. Overwhelming evidence shows that the
bronchial-pulmonary system is very sensi-
tive to ozone and this gas should never be
inhaled.
67
2. This is very true because the respiratory tract
lining fluid is constituted by a very thin,
watery film containing a minimal amount of
antioxidants that makes mucosal cells ex-
tremely vulnerable to oxidation. The oppo-
site situation occurs for blood cells
suspended in plasma, which has a potent
antioxidant capacity (1.23/1.83 mmol/l)
able to tame any ozone dose within the
therapeutic range (10/80 mg/ml).
3. Saline-washed erythrocytes suspended in
saline undergo extensive hemolysis after
ozone exposure.
12
4. Cells in culture, even if exposed to very low
ozone concentrations for a long time, un-
dergo apoptosis.
74
5. One-hour exposure of saline-diluted blood
to 5 mM of ozone induces genotoxic effects
on leukocyte.
75
But is ozone always toxic?
As a matter of fact millions of O3-AHT, even if
performed in an empirical fashion during the past
three decades, has neither yielded acute nor chronic
toxic effects. According to Jacobs
76 this procedure
has yielded the lowest number of medical complica-
tions. However, four deaths have been recorded due
to pulmonary embolism, which occurred during
direct intravenous administration of O2/O3,a n
application prohibited by the European Society of
Ozonetherapy since 1983. Thus ozone seems like
Janus and his two faces require an explanation. This
is now reasonably clear. Since 1988 we have inves-
tigated the problem in a scientific way using precise
ozone generators, which allow checking ozone
concentration in real time by a photometer calibrated
with the classical iodometric method. A review
61 and
a critical book
3 have extensively clarified the issue
but this does not seem sufficient to dispel the dogma
that ‘ozone is always toxic’. However, we now
consider ozone as a real drug that must be used
with caution after having carefully defined its ther-
apeutic window. First, the ozone must be calibrated
against the antioxidant capacity of the patient’s blood
in order to control the potential ozone toxicity.
Second, expert scientists in free radicals ought to
distinguish the chronic intracellular oxidative stress
typical of several pathologies by the transitory
(5 min) calculated oxidative stress occurring when a
precise volume of blood is exposed ex vivo to an
equal volume of gas (O2 /O3) with well-defined
ozone concentrations ranging from 20 up to 40 mg/ml
per ml of blood. It needs to be emphasized that the
exogenous oxidative stress caused by ozone in blood
is due to the fact that ozone, once dissolved in the
plasmatic water, instantaneously reacts with biomo-
lecules and disappears but generates ROS, among
which are H2O2 and LOPs. These are the effective
ozone messengers that interact with a variety of cells
and elicit the now-termed ‘therapeutic shock’ due to
the multiform biological responses. That ozone acts
as a real chemical drug is proved by the fact that the
ozone messengers, to be effective, must reach a
threshold because otherwise there are no biological
effects and the therapeutic results, if any, are due to a
placebo effect. Although we have proven that ozone
therapy is not a nebulous approach and has been
shown amenable to a precise scientific scrutiny, it is
probable that much still remains to be uncovered.
Everyone knows that plasma and blood cells
contain an almost redundant antioxidant system
made up of hydro-liposoluble compounds and anti-
oxidant enzymes. During aging or pathologic condi-
tions, this is not sufficient to correct the intracellular
oxidative stress, but normally it is adequate to tame
ozone toxicity while allowing the generation of ROS
and LOPs. Thus all data emphasizing ozone toxicity
can be easily dismissed because the following is now
well proven:
1. Blood is a much more ozone-resistant ‘tis-
sue’ than the respiratory tract that, for
anatomic, biochemical and metabolic rea-
sons, is always at a loss when exposed to
ozone, and therefore it is wrong to extra-
polate ozone toxicity for the pulmonary
system to blood.
2. Washed and saline-resuspended erythro-
cytes, fully depleted of the plasmatic anti-
oxidants, are obviously very sensitive to
ozonation, and all of these unnatural data
have neither physiological nor practical
significance.
3. The same occurs for cells cultured in anti-
oxidant-poor media and exposed continu-
ously for days to ozone. Surprisingly, cell
biologists reported only the ozone concen-
tration but have neither calculated nor taken
into account the cumulative dose of ozone
that after a long exposure kills the cells.
4. The conclusion is that, although ozone is
potentially mutagenic, so far all experimen-
tal data performed in physiological condi-
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shown any cell damage nor adverse effects
in patients. As a matter of fact, blood is
exposed to ozone concentrations (0.21/1.68
mM) lower than the mutagenic ones (1.5/
5.6 mM). The question of whether ozone is
genotoxic and mutagenic is a critical one
and has been extensively discussed else-
where.
3 What has never been entirely ap-
preciated is the fact that we can only use an
ozone dose that does not overwhelm the
antioxidant capacity of blood.
Hopefully this discussion should put an end to the
confusion between the endogenously constant oxi-
dative stress due to the oxygen and the transitory and
occasional therapeutic ‘shock’ due to precise blood
ozonation. A point that should not be overlooked is
that ozone messengers, by acting on different cells,
elicit a variety of biological effects that cannot ever be
dreamed of with the usual reductionist approach of
using a drug for a single target. This consideration
can explain the far superior therapeutic effect of
parenteral and topical ozone therapy in advanced
cases of chronic limb ischemia to the conventional
infusion of prostanoids. Another relevant character-
istic is that the judicious strategy ‘start low, go slow’ in
using ozone is able to induce in patients the
adaptation to the chronic oxidative stress (i.e. ozone)
paradoxically upregulates the antioxidant defenses.
The scientific evaluation of ozone therapy efficacy
remains the crucial point: results accrued during the
past 20 years show that is very useful in chronic limb
ischemia, ARMD, chronic infectious diseases and,
most surprising, in orthopedics and even in dentistry
after conventional medicine has failed to provide a
real advantage. There are no adverse effects and most
of the patients report a feeling of wellness. The
efficacy remains uncertain in other pathologies such
as neurodegenerative, autoimmune diseases and
cancer because clinical experience is fragmentary
and anecdotal. However, orthodox medicine remains
skeptical because controlled clinical trials are few and
are not considered satisfactory. Unfortunately our
good will is not sufficient to overcome prejudice and
lack of sponsors. It is distressing to realize that a
wrong dogma, commercial interests and the disin-
terest of Health Authorities delay the application of a
medical approach that could help billions of patients,
particularly in poor countries.
Finally, this paper may serve the purpose of
opening a fruitful discussion on the beneficial versus
the toxicological actions of ozone, and a referee has
proposed that the debate may be hosted as a forum
by Mediators of Inflammations.
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